Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM
Clinical trial NCT03940833 · UNKNOWN
Trial details
- NCT number
- NCT03940833
- Sponsor
- Asclepius Technology Company Group (Suzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.